Matthew J. Schuchert, MD, Brian L

Slides:

Advertisements

Similar presentations

What Predicts Long-Term Survival After Heart Transplantation

Advertisements

Elizabeth A. David, MD, David T

Outcomes of Major Lung Resection After Induction Therapy for Non-Small Cell Lung Cancer in Elderly Patients Chi-Fu Jeffrey Yang, MD, Nicholas R. Mayne,

Lymphovascular Invasion as a Prognostic Indicator in Stage I Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis Nathan M. Mollberg, DO,

A Propensity-Matched Analysis of Wedge Resection and Stereotactic Body Radiotherapy for Early Stage Lung Cancer Jeffrey L. Port, MD, Bhupesh Parashar,

Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.

Complete Thoracic Mediastinal Lymphadenectomy Leads to a Higher Rate of Pathologically Proven N2 Disease in Patients With Non-Small Cell Lung Cancer

Thomas J. Birdas, MD, Richard P. M

Number of Lymph Nodes and Metastatic Lymph Node Ratio Are Associated With Survival in Lung Cancer Chukwumere E. Nwogu, MD, Adrienne Groman, MA, Daniel.

Outcomes of Sublobar Resection Versus Lobectomy for Stage I Non–Small Cell Lung Cancer: A 13-Year Analysis Amgad El-Sherif, MD, William E. Gooding, MS,

The Society of Thoracic Surgeons Practice Guideline on the Prophylaxis and Management of Atrial Fibrillation Associated With General Thoracic Surgery:

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Comparison of Video-Assisted Thoracoscopic Surgery and Robotic Approaches for Clinical Stage I and Stage II Non-Small Cell Lung Cancer Using The Society.

Comparison of Thoracoscopic Segmentectomy and Thoracoscopic Lobectomy for Small-Sized Stage IA Lung Cancer Chenxi Zhong, MD, Wentao Fang, MD, Teng Mao,

Matthew J. Schuchert, MD, Kristen N

A Nomogram to Predict Recurrence and Survival of High-Risk Patients Undergoing Sublobar Resection for Lung Cancer: An Analysis of a Multicenter Prospective.

Morbidity and Mortality of Major Pulmonary Resections in Patients With Early-Stage Lung Cancer: Initial Results of the Randomized, Prospective ACOSOG.

Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.

Comparison of Surgical Approaches to Recalcitrant Gastroesophageal Reflux Disease in the Patient with Scleroderma Michael S. Kent, MD, James D. Luketich,

Impact of tumor size on outcomes after anatomic lung resection for stage 1A non–small cell lung cancer based on the current staging system Shamus R.

Oncologic Outcomes After Surgical Resection of Subcentimeter Non-Small Cell Lung Cancer Matthew J. Schuchert, MD, Arman Kilic, BS, Arjun Pennathur, MD,

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

How to Keep the Treatment of Esophageal Disease in the Surgeon’s Hands

Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Arjun Pennathur, MD, Andrew C. Chang, MD, Kevin M

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Stereotactic Radiosurgery/Stereotactic Body Radiotherapy for Recurrent Lung Neoplasm: An Analysis of Outcomes in 100 Patients Arjun Pennathur, MD, James.

Induction Chemotherapy is Not Superior to a Surgery-First Strategy for Clinical N1 Non- Small Cell Lung Cancer Paul J. Speicher, MD, Zachary W. Fitch,

Prognostic Predictors in Non-Small Cell Lung Cancer Patients Undergoing Intentional Segmentectomy Terumoto Koike, MD, PhD, Teruaki Koike, MD, PhD, Yasushi.

Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H

Mohamed K. Kamel, MD, Mohamed Rahouma, MD, Benjamin Lee, MD, Sebron W

Expression of Bone Morphogenetic Proteins in Human Lung Carcinomas

Philip W. Smith, MD, Hongkun Wang, PhD, Leo M. Gazoni, MD, K

Chris Dickhoff, MD, Max Dahele, MD, PhD, Sayed M

Brian L. Pettiford, MD, Matthew J

Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R

Roux-en-Y Near Esophagojejunostomy for Intractable Gastroesophageal Reflux After Antireflux Surgery Omar Awais, DO, James D. Luketich, MD, John Tam,

Lobar and sublobar resection with and without brachytherapy for small stage IA non– small cell lung cancer Hiran C. Fernando, FRCS, FRCSEd, Ricardo S.

Thomas J. Birdas, MD, Richard P. M

Matthew J. Schuchert, MD, Kristen N

Clinicopathologic Features of Resected Subcentimeter Lung Cancer

Surgical Considerations for the Management and Resection of Esophageal Gastrointestinal Stromal Tumors Matthew G. Blum, MD, Karl Y. Bilimoria, MD, Jeffrey.

Survival After Lobectomy Versus Segmentectomy for Stage I Non-Small Cell Lung Cancer: A Population-Based Analysis Bryan A. Whitson, MD, PhD, Shawn S.

Use of Amiodarone After Major Lung Resection

Abel Gómez-Caro, MD, Pedro Arguis, MD The Annals of Thoracic Surgery

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non- Small Cell Lung Cancer Feiran Lou, MD, MS, Camelia S. Sima, MD, MS,

Patient Preferences in Treatment Choices for Early-Stage Lung Cancer

Radiofrequency Ablation for the Treatment of Pulmonary Metastases

Selective Mediastinal Lymphadenectomy for Clinico-Surgical Stage I Non–Small Cell Lung Cancer Morihito Okada, MD, PhD, Toshihiko Sakamoto, MD, PhD, Tsuyoshi.

Impact of Pulmonary Function Measurements on Long-Term Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer Mark F. Berry, MD, Chi-Fu Jeffrey.

Lymph Node Assessment and Impact on Survival in Video-Assisted Thoracoscopic Lobectomy or Segmentectomy Haiyu Zhou, MD, Luis F. Tapias, MD, Henning A.

Jonathan D. Spicer, MD, PhD, Jitesh B. Shewale, BDS, PhD, David B

Radiofrequency Ablation for Stage I Non-Small Cell Lung Cancer: Management of Locoregional Recurrence Michael Lanuti, MD, Amita Sharma, MD, Henning Willers,

Preoperative (3-dimensional) computed tomography lung reconstruction before anatomic segmentectomy or lobectomy for stage I non–small cell lung cancer

Arman Kilic, BS, Matthew J. Schuchert, MD, Brian L

Margin Distance Does Not Influence Recurrence and Survival After Wedge Resection for Lung Cancer Giulio Maurizi, MD, Antonio D’Andrilli, MD, Anna Maria.

Predictors of Survival After Operation Among Patients With Large Cell Neuroendocrine Carcinoma of the Lung Florian Eichhorn, MD, Hendrik Dienemann, MD,

Postesophagectomy Chylothorax: Incidence, Risk Factors, and Outcomes

Shared Decision Making and Effective Risk Communication in the High-Risk Patient With Operable Stage I Non-Small Cell Lung Cancer Pamela Samson, MD,

Matthew J. Schuchert, MD, André P

Matthew J. Schuchert, MD, Omar Awais, DO, Ghulam Abbas, MD, Zachary D

Pancreaticopleural Fistula Presenting as Right-Sided Hemothorax

Omar Awais, DO, James D. Luketich, MD, Matthew J

Lobectomy Versus Limited Resection in T1N0 Lung Cancer

Esophagectomy for T1 Esophageal Cancer: Outcomes in 100 Patients and Implications for Endoscopic Therapy Arjun Pennathur, MD, Andrew Farkas, BA, Alyssa.

Matthew J. Schuchert, MD, Thomas G

Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy Tomas Gudbjartsson,

Video-Assisted Thoracoscopic Surgery Is a Safe and Effective Alternative to Thoracotomy for Anatomical Segmentectomy in Patients With Clinical Stage I.

Presentation transcript:

Anatomic Segmentectomy in the Treatment of Stage I Non-Small Cell Lung Cancer Matthew J. Schuchert, MD, Brian L. Pettiford, MD, Samuel Keeley, MD, Thomas A. D’Amato, MD, PhD, Arman Kilic, BS, John Close, MA, Arjun Pennathur, MD, Ricardo Santos, MD, Hiran C. Fernando, MD, James R. Landreneau, James D. Luketich, MD, Rodney J. Landreneau, MD The Annals of Thoracic Surgery Volume 84, Issue 3, Pages 926-933 (September 2007) DOI: 10.1016/j.athoracsur.2007.05.007 Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 (A) Disease-free survival of segmentectomy (gray line) and lobectomy (black line) cohorts. (B) Overall survival of segmentectomy (gray line) and lobectomy (black line) cohorts. The Annals of Thoracic Surgery 2007 84, 926-933DOI: (10.1016/j.athoracsur.2007.05.007) Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Analysis of recurrences (diamonds) based on tumor size and surgical margin. The diagonal line represents a surgical margin/tumor size ratio of 1 over the range of tumors encountered. Note that the significant majority of recurrences (23/27 = 85%) are seen when the margin/tumor ratio is less than 1. The Annals of Thoracic Surgery 2007 84, 926-933DOI: (10.1016/j.athoracsur.2007.05.007) Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions